Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma

Pharmacological Research

Volumn 39, Issue 3, 1999, Pages 175-179

  Sriganth, I Navis Paul ^a   Premalatha, B ^a,b  

^a UNIVERSITY OF MADRAS   (India)

^b MPT Colony ^*  (India)

Author keywords

Cisplatin; Curcumin; Fibrosarcoma; Marker enzymes

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; CISPLATIN; CURCUMIN; GAMMA GLUTAMYLTRANSFERASE; KIDNEY ENZYME; LACTATE DEHYDROGENASE; LIVER ENZYME; TUMOR MARKER; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSARCOMA; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY HOMOGENATE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033106247     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0425     Document Type: Article

References (37)

1. Potter VR. In: Concept in Cancer Medicine. Khan SB, Love RR, Sherman C, Chakravorty R, eds. New York: Grune and Stratton Inc., 1983: 119.
2. Doedhar SD, Sethi R, Sirmal RC. Preliminary study on anti-rheumatic activity of curcumin. Ind J Med Res 1986; 71: 632-4.
3. Rao VC, Rivenson A, Simi B, Reddy SB. Chemoprevention of colon carcinogenesis by dietary curcumin a naturally occurring plant phenolic compound. Cancer Res 1995; 55: 259-66.
4. Kuttan RR, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 1985; 24: 197-202.
5. Nagabhushan M, Amonkar AJ, Bhide SV. In vitro antimutagenicity of curcumin against environmental mutagens. Fd Chem Toxicol 1987; 25: 545-7.
6. Soudamini KKMC, Unnikrishnan K, Sugumaran, Kuttan R. Mutagenicity and antimutagenicity of selected species. Ind J Physiol Pharmacol 1995; 39: 347-51.
7. Stefainini M. Enzymes, isoenzymes and enzyme variants in the diagnosis of cancer. Cancer 1985; 55: 1931-6.
8. Lowry OH, Rosenbrough WJ, Farren AI, Randal RJ. Protein measurement with Polin phenol reagent. J Biol Chem 1951; 193: 265-75.
9. King J. The transferases - Alanine and aspartate transaminases. In: Practical Clinical Enzymology. Van D, ed. London: Nostrand Co., 1965: 121-38.
10. King J. The dehydrogenases or oxidoreductases, lactate dehydrogenase. In: Practical Clinical Enzymology. Van D, ed. London: Nostrand Co., 1965: 83-93.
11. Orlowski K, Meister A. Isolation of γ-glutamyl transpeptidase from dog kidney. J Biol Chem 1965; 240: 338-47.
12. Rosalki SB, Rao D. Serum γ-glutamyl transpetidase activity in alcoholism. Clin Chim Acta 1972; 39: 41-7.
13. Moog F. Acid and alkaline phosphatase in chick embryo. J Cell Cop Physiol 1946; 28: 197-208.
14. King EJ. The hydrolases, acid and alkaline phosphatases. In: Practical Clinical Enzymology. Van D, ed. London: Nostrand Co., 1965: 191.
15. +-ATPase of rat liver. Biochim Biophys Acta 1972; 282: 447-52.
16. Mc Intyre N, Rosalki S. Biochemical investigations in the management of liver disease. In: Hepatobiliary Diseases. Prieto J, Rodes J, Shafritz DA, eds. Berlin: Springer Verlag, 1992: 39-71.
17. 1 in male and female rats relationship with hepatic drug metabolising enzymes. Biochem Pharmacol 1982; 31: 3057-62.
18. Sarathchandra G, Chandra T, Jayasundar S, Murthy PB. Toxicology of Cleistanthus collinus, an indigenous plant acute toxicity study. Ind J Toxicol 1996; 3: 9-17.
19. Wallersteadt S, Olsson R, Walderstrom J. The diagnostic significance of a high ASAT, ALAT ratio in patients with very high serum aminotransferase level. Acta Med Scand 1974; 195: 227-9.
20. Liss G, Greenburg RA, Tamburro CH. Use of serum bile acids in the identification of vinyl chloride hepatotoxicity. Am J Med 1985; 78: 68-76.
21. Mano R, Roveta G, Rezzani R, Rodella L. Changes observed in lactate dehydrogenase activity in fibrosarcoma bearing rats. Bull Soc Ital Biol Sper 1989; 65: 273-8.
22. Engan T, Hannisdal E. Blood analysis as prognostic factor in primary lung cancer. Acta Oncol 1990; 29: 151-4.
23. Bose CH, Mukherjee M. Enzymatic tumour markers in ovarian cancer: A multiparametric study. Cancer Lett 1994; 77: 39-43.
24. Nakashim RA, Scott LJ, Pedersen PL. The role of mitochondrial hexokinase binding in the abnormal energy metabolism of tumour cell lines. Ann NY Acad Sci 1986; 488: 438-9.
25. Bacci G, Arella M, McDonald D, Toni A, Orlandi M, Companacci M. Serum lactate dehydrogenase as a tumour marker in Ewings sarcoma. Tumor 1988; 74: 649-55.
26. Patel PS, Rawal GN, Bala DB. Combined use of serum enzyme levels as tumour markers in cervical carcinoma patients. Tumour Biol 1994; 15: 45-51.
27. Kobayashi T, Kawakubo T. Prospective investigation of tumour markers and risk assessment in early cancer screening. Cancer 1994; 73: 1946-53.
28. Fugiwara K, Katyal SL, Lombardi B. Influence of age sex and cancer on the activities of γ-glutamyl transpeptidase and of dipeptidyl amino peptidase IV in rat tissue. Enzyme 1982; 27: 114-18.
29. Jagat Singh, Anjali Sharma, Yadav SPS, Harbauslal, Serum γ-glutamyl transpeptidase in head and neck cancer. Clin Chim Acta 1991; 203: 375-8.
30. Stack AA, Zeiger E, Pagano DA. Glutathione metabolism by γ-glutamyl transpeptidase leads to lipid peroxidation. Characterization of the system and relevance to hepatocarcinogensis. Carcinogenesis 1993; 14: 183-9.
31. Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF. Selective protection against cis-diamine dichloro platinum by diethyl dithiocarbamate. Cancer Res 1986; 46: 2751-5.
32. Ip C, Dao T. Alternations in serum glycosyl transferase and 5′-nucleotidase in breast cancer patients. Cancer Res 1978; 38: 723-8.
33. Thompson LF, Ruedi JM, O'Connon RD, Bastian JF. Ecto 5′-nucleotidase expression during human B cell development. An explanation for the heterogenicity in B-lymphocyte aceto 5′-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol 1986; 137: 2459-500.
34. Le Hir M, Dubich UC. An ATP-inhibited soluble 5′-nucleotidase of rat kidney. Am J Physiol 1988; 254: F191-5.
35. + dependant ATPases in compensatory renal hypertrophy. Yale J Biol Med 1978; 51: 365-72.
36. Schwartz MK, Bodansky O. Serum 5′-nucleotidase in patients with cancer. Cancer 1965; 18: 886-92.
37. Soudamini KK, Kuttan R. Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol 1989; 27: 227-33.